DK1287822T3 - Orale farmaceutiske mesalazinsammensætninger med kontrolleret frigivelse - Google Patents
Orale farmaceutiske mesalazinsammensætninger med kontrolleret frigivelseInfo
- Publication number
- DK1287822T3 DK1287822T3 DK02026576T DK02026576T DK1287822T3 DK 1287822 T3 DK1287822 T3 DK 1287822T3 DK 02026576 T DK02026576 T DK 02026576T DK 02026576 T DK02026576 T DK 02026576T DK 1287822 T3 DK1287822 T3 DK 1287822T3
- Authority
- DK
- Denmark
- Prior art keywords
- controlled
- oral pharmaceutical
- release oral
- mesalazine
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999MI001316A ITMI991316A1 (it) | 1999-06-14 | 1999-06-14 | Composizioni farmaceutiche orali a rilascio modificato di mesalazina |
EP00935194A EP1198226B1 (en) | 1999-06-14 | 2000-06-08 | Mesalazine controlled release oral pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1287822T3 true DK1287822T3 (da) | 2006-08-28 |
Family
ID=11383159
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02026576T DK1287822T3 (da) | 1999-06-14 | 2000-06-08 | Orale farmaceutiske mesalazinsammensætninger med kontrolleret frigivelse |
DK00935194T DK1198226T3 (da) | 1999-06-14 | 2000-06-08 | Orale, farmaceutiske mesalazinsammensætninger med kontrolleret frigivelse |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00935194T DK1198226T3 (da) | 1999-06-14 | 2000-06-08 | Orale, farmaceutiske mesalazinsammensætninger med kontrolleret frigivelse |
Country Status (18)
Country | Link |
---|---|
US (1) | US6773720B1 (da) |
EP (2) | EP1287822B1 (da) |
JP (2) | JP4727875B2 (da) |
CN (2) | CN100448448C (da) |
AT (2) | ATE235234T1 (da) |
AU (1) | AU5077200A (da) |
CA (1) | CA2377299C (da) |
DE (2) | DE60001835T2 (da) |
DK (2) | DK1287822T3 (da) |
ES (2) | ES2194732T3 (da) |
HK (2) | HK1046247B (da) |
IT (1) | ITMI991316A1 (da) |
MX (1) | MXPA01012888A (da) |
NO (1) | NO329402B1 (da) |
PT (2) | PT1287822E (da) |
RU (1) | RU2245148C2 (da) |
TR (1) | TR200200561T2 (da) |
WO (1) | WO2000076481A1 (da) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
JP4790950B2 (ja) | 1999-06-14 | 2011-10-12 | コスモ・テクノロジーズ・リミテッド | 制御放出および味感遮蔽経口医薬組成物 |
CA2359812C (en) * | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
US8282955B2 (en) | 2001-10-15 | 2012-10-09 | Ferring B.V. | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease |
US9308220B2 (en) | 2001-12-11 | 2016-04-12 | Cosmo Technologies Limited | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
ITMI20012599A1 (it) * | 2001-12-11 | 2003-06-11 | Cosmo Spa | Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int |
US20030118329A1 (en) * | 2001-12-21 | 2003-06-26 | Pere Obrador | Video indexing using high resolution still images |
KR100540035B1 (ko) * | 2002-02-01 | 2005-12-29 | 주식회사 태평양 | 다단계 경구 약물 방출 제어 시스템 |
FR2852843B1 (fr) | 2003-03-24 | 2008-05-23 | Karim Ioualalen | Systeme galenique permettant le masquage du gout |
EP1615619A2 (en) * | 2003-04-23 | 2006-01-18 | Ferring B.V. | Sachet for a pharmaceutical composition |
US7825106B2 (en) * | 2003-09-03 | 2010-11-02 | Agi Therapeutics Ltd. | Modified release formulations and methods of treating inflammatory bowel disease |
US7737133B2 (en) | 2003-09-03 | 2010-06-15 | Agi Therapeutics Ltd. | Formulations and methods of treating inflammatory bowel disease |
GB0322848D0 (en) * | 2003-09-30 | 2003-10-29 | Alpharma Ltd | Tetracycline controlled release pharmaceutical dosage form |
JP2007517050A (ja) * | 2003-12-31 | 2007-06-28 | アクタビス グループ フルータフェーラグ | アトモキセチン製剤 |
CA2553775A1 (en) | 2004-01-20 | 2005-08-11 | Richard F. Harty | Compositions and methods of treatment for inflammatory diseases |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
WO2008011087A2 (en) | 2006-07-19 | 2008-01-24 | The Board Of Regents Of The University Of Texas System | Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
BRPI0622007A2 (pt) * | 2006-09-13 | 2011-12-20 | Procter & Gamble | uso de aminossalicilato para tratar colite ulcerativa |
AU2006348180A1 (en) * | 2006-09-13 | 2008-03-20 | Warner Chilcott Company, Llc | Methods of treatment for ulcerative colitis |
WO2008063746A1 (en) | 2006-11-17 | 2008-05-29 | Shire Development Inc. | Method of treatment for inflammatory bowel disease |
FR2913884A1 (fr) * | 2007-03-21 | 2008-09-26 | Oralance Pharma Sa | Systeme galenique hydrophobe non ionisable |
US20090028944A1 (en) * | 2007-07-16 | 2009-01-29 | Balaji Sathurappan | Pharmaceutical compositions comprising mesalamine |
US20090036414A1 (en) * | 2007-08-02 | 2009-02-05 | Mutual Pharmaceutical Company, Inc. | Mesalamine Formulations |
US20090169622A1 (en) * | 2007-12-27 | 2009-07-02 | Roxane Laboratories, Inc. | Delayed-release oral pharmaceutical composition for treatment of colonic disorders |
WO2010144865A2 (en) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
WO2011045775A1 (en) | 2009-10-16 | 2011-04-21 | Ranbaxy Laboratories Limited | A delayed release pharmaceutical composition of mesalamine |
IT1398643B1 (it) | 2010-03-04 | 2013-03-08 | Cosmo Technologies Ltd | Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa |
EP2425826A1 (en) * | 2010-09-01 | 2012-03-07 | Disphar International B.V. | Mesalazine tablet having improved dissolution |
IT1402047B1 (it) * | 2010-10-19 | 2013-08-28 | Cross Pharma Sa | Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali |
EP2468264A1 (en) | 2010-12-27 | 2012-06-27 | Laboratorios Liconsa, S.A. | Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it |
KR20140035331A (ko) | 2011-01-07 | 2014-03-21 | 엘셀릭스 테라퓨틱스 인코포레이티드 | 화학감각 수용체 리간드-기반 요법 |
WO2013103919A2 (en) | 2012-01-06 | 2013-07-11 | Elcelyx Therapeutics, Inc. | Compositions and methods for treating metabolic disorders |
US9795792B2 (en) | 2011-02-25 | 2017-10-24 | Medtronic, Inc. | Emergency mode switching for non-pacing modes |
US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
EP2800561B1 (en) | 2012-01-06 | 2020-08-19 | Anji Pharma (US) LLC | Biguanide compositions and methods of treating metabolic disorders |
JP6566638B2 (ja) * | 2012-03-07 | 2019-08-28 | サンタラス, インコーポレイテッドSantarus,Inc. | メサラミンの放出制御固形製剤 |
US20150164920A1 (en) | 2012-03-30 | 2015-06-18 | Laboratorios Del Dr. Esteve S.A. | Controlled release formulation comprising mesalamine |
WO2013158928A2 (en) | 2012-04-18 | 2013-10-24 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
JP2015522080A (ja) | 2012-07-11 | 2015-08-03 | エルセリクス セラピューティクス インコーポレイテッド | スタチン、ビグアナイド、およびさらなる薬剤を含む心血管代謝性リスクを減少させるための組成物 |
EP2722058A1 (en) | 2012-10-19 | 2014-04-23 | Cosmo Technologies Ltd | Solid oral composition containing dyes for use in endoscopic diagnosis |
EP2941245B1 (en) | 2013-01-05 | 2024-06-26 | Anji Pharmaceuticals Inc. | Delayed-release composition comprising biguanide |
AU2014219726B2 (en) * | 2013-02-22 | 2018-03-15 | Zeria Pharmaceutical Co., Ltd. | Enteric coated tablet |
JP6294457B2 (ja) | 2013-03-15 | 2018-03-14 | ワーナー チルコット カンパニー, エルエルシーWarner Chilcott Company, Llc | 低減した送達変動性のための複数の投薬要素を備えるメサラミン医薬組成物 |
US9539265B2 (en) | 2013-03-15 | 2017-01-10 | Aihol Corporation | Pharmaceutical formulation containing glycosaminoglycan |
CN104922090B (zh) * | 2015-07-03 | 2017-11-14 | 湖南方盛制药股份有限公司 | 美沙拉秦肠溶缓释微丸 |
EP3162362A1 (de) | 2015-10-30 | 2017-05-03 | Dr. Falk Pharma Gmbh | Optimierte mesalazinhaltige hochdosistablette |
ITUA20162293A1 (it) | 2016-04-05 | 2017-10-05 | Sofar Spa | Processo per formulazioni solide di mesalazina |
US20180147301A1 (en) | 2016-11-28 | 2018-05-31 | Cosmo Technologies Ltd. | Solid oral composition containing dyes |
US10098898B1 (en) | 2017-12-04 | 2018-10-16 | Handa Pharmaceuticals, Llc | Release stable mesalamine dosage forms |
EP3501503A1 (en) * | 2017-12-22 | 2019-06-26 | Cosmo Technologies Ltd. | Solid delivery composition |
EP3662895A1 (en) | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | A process for manufacturing reducing sugar-free 5-asa tablet cores |
IT201800011120A1 (it) | 2018-12-14 | 2020-06-14 | Dpl Pharma S P A | Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati |
CN112587506A (zh) * | 2020-12-09 | 2021-04-02 | 南京森博医药研发有限公司 | 一种用于制备美沙拉嗪肠溶缓释胶囊的方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4921757A (en) * | 1985-04-26 | 1990-05-01 | Massachusetts Institute Of Technology | System for delayed and pulsed release of biologically active substances |
JPS6248618A (ja) * | 1985-08-27 | 1987-03-03 | Zeria Shinyaku Kogyo Kk | 徐放性製剤およびその製造法 |
JP2893191B2 (ja) | 1988-11-08 | 1999-05-17 | 武田薬品工業株式会社 | 放出制御性マトリックス剤 |
IL92343A0 (en) * | 1988-12-20 | 1990-07-26 | Gist Brocades Nv | Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them |
IL92344A0 (en) * | 1989-01-04 | 1990-07-26 | Gist Brocades Nv | Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules |
JPH02282323A (ja) * | 1989-04-21 | 1990-11-19 | Shin Etsu Chem Co Ltd | 徐放性錠剤の製造方法 |
JPH03232814A (ja) * | 1990-02-08 | 1991-10-16 | Shin Etsu Chem Co Ltd | 徐放性錠剤の製造方法 |
IE61651B1 (en) | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
GB2253346A (en) * | 1991-02-22 | 1992-09-09 | John Rhodes | Delayed release oral dosage forms for treatment of intestinal disorders |
JP3011752B2 (ja) * | 1990-10-23 | 2000-02-21 | フロイント産業株式会社 | 徐放性製剤およびその製造方法 |
JP2829794B2 (ja) * | 1991-02-08 | 1998-12-02 | エスエス製薬 株式会社 | 徐放性経口投与型プラノプロフェン製剤 |
JPH0624962A (ja) * | 1992-07-09 | 1994-02-01 | Green Cross Corp:The | 腸溶徐放性製剤 |
JP2616252B2 (ja) * | 1992-10-16 | 1997-06-04 | 日本新薬株式会社 | ワックスマトリックスの製法 |
US5911980A (en) * | 1996-06-27 | 1999-06-15 | Macrochem Corporation | Lipophilic and amphiphilic or hydrophilic film-forming polymer compositions, and use thereof in topical agent delivery system and method of delivering agents to the skin |
AU5775398A (en) * | 1996-12-17 | 1998-07-15 | Poli Industria Chimica S.P.A. | Site-specific controlled release dosage formulation for mesalamine |
US5851555A (en) * | 1997-08-15 | 1998-12-22 | Fuisz Technologies Ltd. | Controlled release dosage forms containing water soluble drugs |
JP4790950B2 (ja) * | 1999-06-14 | 2011-10-12 | コスモ・テクノロジーズ・リミテッド | 制御放出および味感遮蔽経口医薬組成物 |
-
1999
- 1999-06-14 IT IT1999MI001316A patent/ITMI991316A1/it unknown
-
2000
- 2000-06-08 JP JP2001502815A patent/JP4727875B2/ja not_active Expired - Lifetime
- 2000-06-08 ES ES00935194T patent/ES2194732T3/es not_active Expired - Lifetime
- 2000-06-08 EP EP02026576A patent/EP1287822B1/en not_active Expired - Lifetime
- 2000-06-08 US US10/009,491 patent/US6773720B1/en not_active Expired - Lifetime
- 2000-06-08 DE DE60001835T patent/DE60001835T2/de not_active Expired - Lifetime
- 2000-06-08 CN CNB2005100833798A patent/CN100448448C/zh not_active Expired - Lifetime
- 2000-06-08 DK DK02026576T patent/DK1287822T3/da active
- 2000-06-08 MX MXPA01012888A patent/MXPA01012888A/es unknown
- 2000-06-08 DE DE60027608T patent/DE60027608T2/de not_active Expired - Lifetime
- 2000-06-08 ES ES02026576T patent/ES2262749T3/es not_active Expired - Lifetime
- 2000-06-08 RU RU2002100365/15A patent/RU2245148C2/ru active
- 2000-06-08 TR TR2002/00561T patent/TR200200561T2/xx unknown
- 2000-06-08 EP EP00935194A patent/EP1198226B1/en not_active Expired - Lifetime
- 2000-06-08 PT PT02026576T patent/PT1287822E/pt unknown
- 2000-06-08 WO PCT/EP2000/005321 patent/WO2000076481A1/en active Search and Examination
- 2000-06-08 AT AT00935194T patent/ATE235234T1/de active
- 2000-06-08 CN CN008088896A patent/CN1217665C/zh not_active Expired - Lifetime
- 2000-06-08 AT AT02026576T patent/ATE324104T1/de active
- 2000-06-08 CA CA002377299A patent/CA2377299C/en not_active Expired - Lifetime
- 2000-06-08 PT PT00935194T patent/PT1198226E/pt unknown
- 2000-06-08 AU AU50772/00A patent/AU5077200A/en not_active Abandoned
- 2000-06-08 DK DK00935194T patent/DK1198226T3/da active
-
2001
- 2001-12-14 NO NO20016107A patent/NO329402B1/no not_active IP Right Cessation
-
2002
- 2002-10-30 HK HK02107880.6A patent/HK1046247B/zh unknown
-
2006
- 2006-05-18 HK HK06105756.7A patent/HK1085669A1/xx unknown
-
2009
- 2009-10-30 JP JP2009250047A patent/JP5235839B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1198226T3 (da) | Orale, farmaceutiske mesalazinsammensætninger med kontrolleret frigivelse | |
CA2158630A1 (en) | Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability | |
DZ2685A1 (fr) | Formulation pharmaceutique orale à libération prolongée. | |
FR2825023B1 (fr) | Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif | |
DE60135674D1 (de) | Nateglinid enthaltende präparate | |
ITMI20021726A1 (it) | Macrolidi ad attivita' antiinfiammatoria. | |
DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
DK515489D0 (da) | Dispergerbar laegemiddelformulering | |
JP2000159790A5 (da) | ||
IT1284604B1 (it) | Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva | |
ES2194793T3 (es) | Microcapsulas para la liberacion prolongada de farmacos. | |
RS50074B (sr) | Farmaceutski preparat koji sadrži paracetamol i drotaverin | |
DE59501945D1 (de) | Orale Arzeimittelzubereitung enthaltend Diclofenac-Natrium und eine organische Säure | |
NO20041878L (no) | Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel. | |
DE60029946D1 (de) | Arzneimittel gegen glomerulosclerose | |
ITMI20000972A0 (it) | Formulazioni farmaceutiche, a rilascio modificato, con elevata biodisponibilita', contenenti principi attivi ad attivita' antibiotica. | |
NO160258C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridazinonimin-derivater. | |
IT8719351A0 (it) | Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative. | |
ITMI912238A1 (it) | Composti ad attivita' mucolitica e antisettica, procedimento per la loro preparazione e relative composizioni farmaceutiche | |
IT8619384A0 (it) | Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative. | |
FR2878443B1 (fr) | Composition pharmaceutique, destinee a l'administration par voie orale de principe(s) actif(s) fortement gastro-labile(s et sa preparation | |
IT8919283A0 (it) | Composizione farmaceutica comprendente come ingrediente attivo 3 n piperidinometil azino metilrifamicina s. |